Back to Person-Based Marketing (PBM)

    Influ2 vs Propensity · 2026

    What's the difference between Influ2 and Propensity?

    Short answer

    Influ2 is the enterprise PBM platform for running paid ads against named individuals at scale. Propensity is the SMB/mid-market option that bundles buying-committee identification with multi-channel activation—paid, outbound, and CRM.

    Vendors update features and pricing often. For the most accurate, up-to-date details, always check Influ2's site and Propensity's site directly.

    Influ2 and Propensity both operationalize Person-Based Marketing—putting paid creative in front of named decision-makers rather than broad audiences. Influ2 is the enterprise standard for ABM/PBM-mature teams running named-person ads on LinkedIn, Meta, and the web.

    Propensity is the SMB/mid-market option that bundles buying-committee identification with multi-channel activation—paid, outbound, and CRM—without requiring a full ABM ops function.

    Influ2 vs Propensity: at-a-glance

    Side-by-side capability comparison.

    Legend:YesBest in classPartialNo
    Influ2
    • Named-person paid targetingBest in class
    • Buying-committee identificationYes
    • Multi-channel activation (paid + outbound + CRM)Partial
    • SMB / mid-market pricingNo
    • Enterprise ABM workflow depthBest in class
    Propensity
    • Named-person paid targetingYes
    • Buying-committee identificationBest in class
    • Multi-channel activation (paid + outbound + CRM)Best in class
    • SMB / mid-market pricingBest in class
    • Enterprise ABM workflow depthYes

    Features and pricing tiers change frequently. Always confirm the latest details on each vendor's official website before making a buying decision.

    Why is Influ2 right for my business?

    Influ2 is the right pick when named-person paid targeting is the cornerstone of your ABM motion and you have the ops team to run it.

    Enterprise B2BNamed-person adsABM-mature
    • You're enterprise B2B with mature ABM ops.
    • Named-person paid targeting is the primary use case.
    • You need committee-driven deal orchestration at scale.

    Why is Propensity right for my business?

    Propensity is the right pick if you want PBM-grade targeting plus multi-channel activation in one affordable platform.

    SMB / mid-marketMulti-channel PBMFast time-to-value
    • You're SMB or mid-market without a dedicated ABM function.
    • You want PBM bundled with outbound and CRM activation.
    • You need fast time-to-value without enterprise pricing.

    Which is better, Influ2 or Propensity?

    Influ2 wins for enterprise PBM-mature teams. Propensity wins for SMB/mid-market teams that want PBM without an ABM ops function.

    Frequently asked questions

    Which is more affordable?

    Propensity, by a wide margin. Influ2 is enterprise-priced. Always check current vendor pricing.

    Which has better identification?

    Propensity for buying-committee discovery; Influ2 for activating against a list you already own.

    Can I run both?

    Rare—they overlap heavily on activation. Most teams pick one.

    Which works better with LinkedIn ads?

    Both integrate, but Influ2's named-person LinkedIn targeting is the more mature implementation.

    Still deciding between Influ2 and Propensity?

    Our consultants can evaluate both tools against your specific stack, budget, and go-to-market motion.

    Ready to stop guessing?

    Whether you need a quick automation fix or a full infrastructure overhaul, let's walk through your biggest manual challenge.